Cargando…
Interleukin 21 (IL-21) regulates chronic allograft vasculopathy (CAV) in murine heart allograft rejection
IL-21 is the most recently discovered common gamma-chain cytokine that promotes persistent T-cell responses in chronic infections, autoimmunity and cancer. However, the therapeutic potential of inhibiting the IL-21-BATF signaling axis, particularly in transplant rejection, remains unclear. We used h...
Autores principales: | Khattar, Mithun, Baum, Caitlin E., Schroder, Paul, Breidenbach, Joshua D., Haller, Steven T., Chen, Wenhao, Stepkowski, Stanislaw |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6874341/ https://www.ncbi.nlm.nih.gov/pubmed/31756235 http://dx.doi.org/10.1371/journal.pone.0225624 |
Ejemplares similares
-
Interleukin-21 Is a Critical Regulator of CD4 and CD8 T Cell Survival during Priming under Interleukin-2 Deprivation Conditions
por: Khattar, Mithun, et al.
Publicado: (2014) -
Transient Combination Therapy Targeting the Immune Synapse Abrogates T Cell Responses and Prolongs Allograft Survival in Mice
por: Schroder, Paul M., et al.
Publicado: (2013) -
Vascular rejection in cardiac allograft vasculopathy: Impact on graft survival
por: Nair, Nandini
Publicado: (2022) -
miR‐21 antagonism reprograms macrophage metabolism and abrogates chronic allograft vasculopathy
por: Usuelli, Vera, et al.
Publicado: (2021) -
Small Molecule Tyrosine Kinase Inhibitor Nintedanib Reduces Development of Cardiac Allograft Vasculopathy in Murine Aortic Allografts
por: Gocht, Annika, et al.
Publicado: (2018)